Pomology: Top > Research

+ Main Category

Crops: 672

Biology: 398

Research: 2032

Business: 39

Home Gardening: 73

+ Tell a Friend

Fill out the information below to email a friend a brief note about 'Pomology: Fruit Cultivation and Production'

+ Top 10

TropHort: Biology, Agriculture, Horticulture and Forestry

Olericulture: Vegetable Cultivation and Production

Pomelo - Wikipedia, the free encyclopedia

Apple - Wikipedia, the free encyclopedia

Viticulture - Wikipedia, the free encyclopedia

Information Sheet - Apple Facts

Grape and wine industry.

Texas Winegrape Network - A Viticulture Resource for Grape Growers.

Life and Earth Sciences Social Network

Table Grape Cultivars for Illinois.

+ Directory Statistics

Links: 1182
Categories: 54
Registered Users: 178
Mailing List Subscribers: 24

+ Pagerank Statistics

PR 7

3 site(s)

PR 6

42 site(s)

PR 5

88 site(s)

PR 4

184 site(s)

PR 3

207 site(s)

PR 2

95 site(s)

PR 1

32 site(s)

+ Join Mailing List

Joining mailing list will entitle you to receive occasional emails informing you of news and updates to the site and any special offers that may be of interest to you.

Research > Chapter 10004

Bookmarks

Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties

Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1

Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1

Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1

Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: A regulatory circuit

Interferon regulatory factor 7-mediated responses defective cord blood plasmacytoid dendritic cells.

Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-kappa B, and PU.1

Interferon regulatory factor element interferon regulatory factor 1 induction major histocompatibility complex class I genes neural cells.

Interferon regulatory factor family of transcription factors and regulation of oncogenesis.

Interferon regulatory factor gene messenger ribonucleic acid expression answer interferon-beta gliomas.

Interferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors

Interferon regulatory factor-1 (IRF- 1) suppression derepression endometrial tumorigenesis cancer progression.

Interferon regulatory factor-1 (IRF-1) activates synthetic IRF-1-responsive sequence (GAAAGT)-4 Saccharomyces cerevisiae.

Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis

Interferon regulatory factor-1 (IRF-1) mediator interferon-gamma stimulated attenuation telomerase activity human telomerase reverse transcriptase (hTERT) expression.

Interferon regulatory factor-1 protective gene intestinal inflammation - function TCR gamma delta T cells interleukin-18-binding protein.

Interferon regulatory factor-1 down-regulates cytokine-induced IP-10 expression pancreatic islets.

Interferon regulatory factor-1 expression human uterine endometrial carcinoma.

Interferon regulatory factor-1 gene abnormality loss growth inhibitory influence interferon-alpha human hepatoma cell lines.

Interferon regulatory factor-1 gene deletion decreases glomerulonephritis MRL/lpr mice.

Interferon regulatory factor-1 immunoreactivity in neurons and inflammatory cells following ischemic stroke in rodents and humans

Interferon regulatory factor-1 major regulator epidermal growth factor receptor gene expression.

Interferon regulatory factor-1 prerequisite constitutive expression IFN-gamma-induced upregulation B7-H1 (CD274).

Interferon regulatory factor-1 required T helper 1 immune answer vivo.

Interferon regulatory factor-1 required interferon-gamma-induced MHC class I genes astrocytes.

Interferon regulatory factor-1 mediates PPARgamma-induced apoptosis in vascular smooth muscle cells

Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis ovarian carcinoma cells.

Interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (Faslodex, Fulvestrant)

Interferon regulatory factor-1 polymorphisms are associated with the control of Plasmodium falciparum infection.

Interferon regulatory factor-1 regulates reconstituted extracellular matrix (rECM)-mediated apoptosis human mammary epithelial cells.

Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis

Interferon regulatory factor-1, interferon-b, reovirus-induced myocarditis.

Interferon regulatory factor-1, interferon-beta, reovirus-induced myocarditis.

Interferon regulatory factor-1-induced apoptosis mediated ligand-independent fas-associated death domain pathway breast cancer cells.

Interferon regulatory factor-2 directs transcription from the gp91-phox promoter

Interferon regulatory factor-2 directs transcription from the gp91phox promoter

Interferon regulatory factor-2 drives megakaryocytic differentiation

Interferon regulatory factor-2 is a transcriptional activator in muscle where it regulates expression of vascular cell adhesion molecule-1

Interferon regulatory factor-2 physically interacts NF-kappa-B vitro inhibits NF-kappa-B induction major histocompatibility class I beta-2-microglobulin gene expression transfected human neuroblastoma cells.

Interferon regulatory factor-2 point mutations human pancreatic tumors.

Interferon regulatory factor-2 regulates cell growth through its acetylation

Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, immune cell infiltration hepatitis C virus patients.

Interferon regulatory factor-3 is an in vivo target of DNA-PK

Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappaB

Interferon regulatory factor-5 genetically systemic lupus erythematosus African Americans.

Interferon regulatory factor-6. gene predisposing extracted cleft lip cleft palate Belgian population.

Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators

Interferon regulatory factor-8 indispensable expression promyelocytic leukemia structure nuclear bodies myeloid cells.

Interferon regulatory factor-9 (IRF-9) mediates short term host protection, promotes long term immune injury evolution myocarditis leading dilated cardiomycipathy.

Interferon regulatory factor-9 (irf-9) mediates short term host protection, promotes long term immune injury evolution myocarditis dilated cardiomyopathy.

Interferon regulatory factor-two restricts expression of interferon-stimulated genes to the endometrial stroma and glandular epithelium of the ovine uterus

Interferon regulatory factors 4 8 stimulate expression Ikaros Aiolos down-regulate pre-B-cell receptor promote cell-cycle withdrawal pre-B-cell progress.

Interferon regulatory factors 4 8 stimulate expression Ikaros withdrawal pre-B-cell progress.

Interferon regulatory factors IRF5 IRF7 inhibit growth stimulate senescence immortal Li-Fraumeni fibroblasts.

Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro

Interferon regulatory factors are transcriptional regulators of adipogenesis

Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells

Interferon regulatory factors: Growth control and histone gene regulation-it's not just interferon anymore

Interferon regulatory factors - The generation.

Interferon regulatory factors - generation.

Interferon regulatory transcription factors constitutively expressed spatially regulated mouse lens.

Interferon similar leukocyte inclusions acquired immune insufficiency syndrome localization cells.

Interferon similar leukoencephalopathy patient renal cell carcinoma.

Interferon similar mental deterioration behavioral patients renal cell carcinoma.

Interferon release means T-cell answer coccidial antigens chickens.

Interferon release means cell answer coccidial antigens chickens.

Interferon removes receptors blocks division daudi cells.

Interferon science BC (Before Cloning).

Interferon science - Impact understanding transcriptional control.

Interferon resistance independent copy numbers benign HPV-induced lesions.

Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication

Interferon resistance of hepatitis C virus genotype 1b: Relationship to nonstructural 5A gene quasispecies mutations

Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations

Interferon resistance hepatitis C virus replicon-harbouring cells attributable functional disruption type I interferon receptors.

Interferon resistance promotes oncolysis influenza virus NSI1-deletion mutants.

Interferon tolerant cell line lacks fatty acid cyclo oxygenase ec 1.14.99.1 activity.

Interferon answer depends viral transcription human papillomavirus-containing lesions.

Interferon response element of the human gene 6 16

Interferon answer heterogeneity - Activation pro-inflammatory answer interferon alpha beta - potential basis responses interferon beta MS.

Interferon answer cats.

Interferon answer chronic myeloid leukaemia correlates ABL/BCR expression. study.

Interferon answer colostrum-deprived newborn calves infested bovine rotavirus - potential function control pathogenicity.

Interferon response in normal and Aleutian disease virus-infected mink

Interferon response in normal and aleutian disease virus infected mink

Interferon answer pigs - Molecular biological aspects.

Interferon answer guinea swine infested junin virus.

Interferon answer stimulated Toll-like receptor signaling.

Interferon answer dipyridamole lupus erythematosus patients.

Interferon response to human di ploid cell strain rabies vaccines in man

Interferon responses maternal fetal mice.

Interferon responses schizophrenia major depressive disorders.

Interferon responses leukocytes multiple sclerosis.

Interferon responses peripheral blood mononuclear cells normal leukemic children.

Interferon responses lymphocyte populations inbred mice varying sensitivity toern equine encephalomyelitis virus.

Interferon responsive regulatory elements in the promoter of the human 2' 5' oligoadenylate synthetase gene

Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype

Interferon retinitis. case report.

Interferon rna of embryonic origin is expressed transiently during early pregnancy in the ewe

Interferon selectively inhibits the expression of mitochondrial genes a novel pathway for interferon mediated responses

Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon-mediated responses

Interferon selectively inhibits the synthesis of Mayaro virus glycoproteins

Interferon sensitive insensitive major histocompatibility complex variants murine thymoma differentially tolerant methotrexate antibody directed liposomes immunotoxin.

Interferon sensitive expression membrane bound immuno globulin human lymphoid bone marrow derived cell line persistently infested herpes simplex virus.

Interferon sensitive mutants mengo virus part 1 isolation biological characterization.

Interferon sensitivity expression histone H5/H1-o-vaccinia thymidine kinase fusion gene expressed recombinant vaccinia viruses enhanced shortening histone sequence.

Interferon sensitivity expression histone H5/H1o-vaccinia thymidine kinase fusion genes expressed recombinant vaccinia viruses enhanced shortening histone sequence.

Interferon sequence homology receptor binding activity ovine trophoblast antiluteolytic protein.

Interferon signal transduction

Interferon signal transduction biphenyl dimethyl dicarboxylate/amantadine anti-HBV activity HepG2 2.2.15.

Interferon signaling cure outcome chronic hepatitis C.

Interferon signaling is dependent on specific tyrosines located within the intracellular domain of IFNAR2c. Expression of IFNAR2c tyrosine mutants in U5A cells

Interferon signaling pathways.

Interferon signalling network innate defence.

Interferon special cellular receptors human cell cultures differing sensitivity alpha interferon.

Interferon specific effects on protein synthesis in p 3hr 1 cells

Interferon specificity evidence xenogenous chimerism hemopoietic tissue.

Interferon stabilization enhancement rare earth salts.

Interferon standardization designations.

Interferon standards memorandum.

Interferon condition B- T-lymphocyte count healthy Macaca mulatta diverse age.

Interferon condition functional activity phagocytes children recurrent bronchitis.

Interferon status measles virus infection.

Interferon status HL-A scheme antigens. Unilocular hydatidosis.

Interferon status activity double stranded rna dependent enzymes healthy volunteers influenza patients treated human recombinant alpha 2 interferon reaferon.

Interferon status circulating immunoglobulins interferon therapy respiratory papillomatosis children.

Interferon status disorders patients urticaria angioneurotic edema presence frequent acute respiratory viral infections correction reaferon.

Interferon status genital infections.

Interferon status helminthiases opisthorchiasis.

Interferon status helminthiases communication echinococcus multilocularis infection.

Interferon status helminthiasis report echinococcus granulosus infection.

Interferon status helminthoses. Communication Multilocular hydatidosis.

Interferon status multiple sclerosis.

Interferon status normal subjects.

Interferon status patients nonspecific ulcerous colitis correction interferon inductors.

Interferon status recurrent genital herpes.

Interferon induced double stranded RNA.

Interferon stimulated gene 15 conjugates to endometrial cytosolic proteins and is expressed at the uterine-placental interface throughout pregnancy in sheep

Interferon stimulated gene 15 constitutively produced by melanoma cells induces E-cadherin expression on human dendritic cells

Interferon induced genes interferon sensitive tolerant chronic myelogenous leukemia patients.

Interferon stimulated transcription isolation of an inducible gene and identification of its regulatory region

Interferon stimulates cholesterol and phosphatidylcholine synthesis but inhibits cholesterol ester synthesis in HeLa-S3 cells

Interferon stimulates cholesterol and phosphatidylcholine synthesis but inhibits cholesterol ester synthesis in hela s 3 cells

Interferon stimulates expression 2 5 oligoadenylate synthetase mhc class antigens insulin producing cells.

Interferon stimulation influence polysaccharide acanthopanax senticosus sodium carboxy methyl starch 801 7811 cell culture.

Interferon stimulatory properties immunomodulators.

Interferon structural genes do not participate in quantitative regulation of interferon production by if loci as shown in c 57bl 6 mice that are congenic with balb c mice at the alpha interferon gene cluster

Interferon super induction human cell cultures.

Interferon suppresses antigen stimulated mitogen stimulated leukocyte migration inhibition.

Interferon suppresses cell stimulation factor induction class ii major histocompatibility complex determinants cells.

Interferon suppresses erythromycin metabolism rats human subjects.

Interferon suppresses glutamine synthetase induction chick embryonic neural retina.

Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages related changes in cytoskeletal organization

Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization

Interferon suppresses steroid inducible glutamine synthetase ec 6.3.1.2 biosynthesis embryonic chick neural retina.

Interferon suppresses sympathetic neuronal cell death attributable nerve growth factor deprivation.

Interferon vulnerability cell lines persistently infested hemagglutinating virus japan.

Interferon synthesis human colostral leucocytes.

Interferon synthesis human colostral leukocytes.

Interferon synthesis peripheral blood leukocytes patients bronchial asthma.

Interferon synthesis X-irradiated animals. donor-type serum interferons rat-to-mouse radiation chimeras injected Newcastle disease virus.

Interferon synthesis in human di ploid cells pre treated with insulin

Interferon synthesis mouse peritoneal cells damaged irradiation.

Interferon synthesis rainbow trout fry infection infectious pancreatic necrosis virus.

Interferon synthesis early post implantation mouse embryo.

Interferon synthesis upper respiratory tract intranasal intramuscular vaccination live BHV-1 vaccines.

Interferon synthesis trout carp viral infection.

Interferon synthesis in x irradiated animals part 4 donor type serum interferons in rat to mouse radiation chimeras injected with newcastle disease virus

Interferon synthesis x-irradiated animals. Depression circulating interferon C3H mice whole-body irradiation.

Interferon synthesizing role leukocytes diabetes mellitus patients.

Interferon scheme natural killer cell activity myasthenia gravis.

Interferon scheme defects human malignant melanoma.

Interferon scheme defects malignant T-cells.

Interferon scheme disorders patients virus-associated chlamydial infections.

Interferon scheme acute tick-borne encephalitis influence diverse methods interferon-therapy dynamics medical laboratory indices.

Interferon scheme enzyme activity viral diseases.

Interferon scheme role diverse routes inoculation doses recombinant alpha 2 interferon reaferon.

Interferon scheme functioning patients mycosis fungoides treated diverse therapeutic methods.

Interferon scheme HIV infection.

Interferon scheme acute transient synovitis.

Interferon scheme acute viral hepatitis.

Interferon scheme children initial stages diabetes mellitus.

Interferon scheme ducks infested hepatitis virus.

Interferon scheme patients rheumatoid arthritis sclerodermia systematica.

Interferon scheme patients systemic juvenile chronic arthritis vivo vitro investigations.

Interferon system in primary acute lymphocytic leukemia cells with or without deletions of the alpha beta interferon genes

Interferon scheme schizophrenics therapy.

Interferon scheme indices patients viral myocarditis dilation cardiomyopathy.

Interferon tau (INF tau ) pregnancy recognition.

Interferon tau immunobiological function ruminant reproduction.

Interferon tau secretion cattle embryos vitro fertilized cryopreservation.

Interferon tau-induced hepatocyte apoptosis sheep.

Interferon tau. pregnancy recognition signal.

Interferon tau - paracrine mediator conceptus-maternal dialogue ruminants.

Interferon therapy.

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus

Interferon therapy immunotherapy children respiratory papillomatosis.

Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C

Interferon therapy prevent hepatocellular carcinoma HCV compensated cirrhosis.

Interferon therapy effects activation T-lymphocytes patients systemic lupus erythematosus.

Interferon therapy 2 years longer reduces occurrence hepatocarcinogenesis patients chronic hepatitis C viral infection.

Interferon therapy Behcet's disease.

Interferon therapy HCV-associated glomerulonephritis - Meta-analysis controlled trials.

Interferon therapy Japanese hemophiliacs chronic hepatitis C.

Interferon therapy acute hepatitis C pregnancy.

Interferon therapy acute hepatitis C viral infection review meta-analysis.

Interferon therapy acute posttransfusion hepatitis answer respect anti hepatitis virus antibody status.

Interferon therapy advanced renal cell carcinoma.

Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response

Interferon therapy agnogenic myeloid metaplasia complicated immune hemolytic anemia.

Interferon therapy atopic dermatitis reduces basophil histamine release, reduce serum IgE eosinophilic proteins.

Interferon therapy basal cell carcinoma squamous cell carcinoma.

Interferon therapy brain tumor patients.

Interferon therapy bronchial papillomatosis controlled papillomavirus dna hybridization.

Interferon therapy chronic hepatitis C habitual drinkers - Comparison chronic hepatitis C infrequent drinkers.

Interferon therapy chronic hepatitis delta children.

Interferon therapy chronic chronic delta liver disease hemophilia.

Interferon therapy condylomata acuminata.

Interferon therapy condylomatous vulvitis.

Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant

Interferon therapy hepatitis C.

Interferon therapy hepatitis C virus (HCV)-related advanced chronic hepatitis cure recurrent hepatocellular carcinoma. successful case.

Interferon therapy hepatocellular carcinoma patients HCV-RNA levels.

Interferon therapy laryngeal papillomatosis adults.

Interferon therapy multiple sclerosis-Enhanced risk autoimmune diseases?

Interferon therapy non-A, non-B hepatitis. pilot study review literature.

Interferon therapy orbital infiltration secondary Erdheim-Chester disease.

Interferon therapy patients 60 years age chronic hepatitis C.

Interferon therapy ph 1 positive cml patients relapsing cell depleted allogeneic bone marrow transplantation.

Interferon therapy primary brain tumors local administration.

Interferon therapy primary brain tumors dna examination survival time.

Interferon therapy anti-HBe positive form chronic hepatitis B.

Interferon therapy type C hepatitis.

Interferon therapy improves irregular regeneration hepatocytes liver patients C-viral chronic hepatitis liver cirrhosis.

Interferon therapy HBeAg positive chronic hepatitis reduces progression cirrhosis hepatocellular carcinoma.

Interferon therapy LKM-1 positive patients chronic hepatitis C - Follow-up quantitative radioligand assay CYP2D6 antibody detection.

Interferon therapy acute lymphocytic leukemia hepatitis childhood.

Interferon therapy chronic hepatitis C virus - Proof diverse outcome respect diverse viral strains.

Interferon therapy chronic hepatitis C - Evaluation dose maintenance schedule responder patients.

Interferon therapy in congenital dyserythropoietic anemia type I/II

Interferon therapy disseminated renal cell carcinoma.

Interferon therapy experimental semliki forest virus disease mice.

Interferon therapy hemodialysis patients chronic hepatitis C - Investigation tolerance, efficacy post-transplantation.

Interferon therapy hodgkins disease case report.

Interferon therapy intravenous drug users HIV-associated idiopathic thrombocytopenic purpura.

Interferon therapy juvenile laryngeal papillomatosis.

Interferon therapy liver cirrhosis type C.

Interferon therapy liver/kidney microsomal antibody type 1-positive patients chronic hepatitis C.

Interferon therapy multiple myeloma.

Interferon therapy multiple myeloma failure human fibroblast interferon administration affect light chain disease.

Interferon therapy myelomatosis.

Interferon therapy neoplastic disease report.

Interferon therapy neoplastic diseases.

Interferon therapy urothelial tumor.

Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients With chronic hepatitis C virus infection: A preliminary study

Interferon therapy lowers rate progression hepatocellular carcinoma chronic hepatitis C significantly advanced stage. retrospective study 1148 patients.

Interferon therapy Child A liver cirrhosis.

Interferon therapy Turkish patients chronic hepatitis B virus infection.

Interferon therapy aids kaposi's sarcoma disseminated malignant melanoma.

Interferon therapy chronic delta hepatitis patients cured pediatric malignancies potential harmful influence.

Interferon therapy chronic hepatitis C - Manipulation non-responders.

Interferon therapy infectious diseases - The condition problem prospects.

Interferon therapy multiple sclerosis.

Interferon therapy hodgkin's lymphoma.

Interferon therapy relapsed refractory hodgkin's disease cancer leukemia group study 8652.

Interferon therapy chronic hepatitis medical significance measurement peripheral lymphocytic 2 5 oligoadenylate synthetase.

Interferon therapy preemptive partial splenic embolization hepatitis C patients thrombocytopenia.

Interferon therapy extended life expectancy chronic hepatitis C patients.

Interferon therapy reduces the risk for hepatocellular carcinoma

Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan

Interferon therapy hbeag positive chronic hepatitis type correlation disappearance hbeag medical features.

Interferon therapy, busulfan restores normal-sized megakaryopoiesis CML comparative histo- immunomorphometric study.

Interferon therapy-responsive brain metabolic abnormalities case adult-onset subacute sclerosing panencephalitis evaluated 1H MRS examination.

Interferon titration plaque test bentonite layer.

Interferon transiently modulates intranuclear signalling scheme erythroleukemia friend cells.

Interferon treated cells release vesicular stomatitis virus particles lacking glyco protein spikes correlation with biochemical data

Interferon cure enhances expression underphosphorylated (biologically-active) retinoblastoma protein human papilloma virus-infected cells inhibitory TGF-beta-1/IFN-beta cytokine pathway.

Interferon cure chronic hepatitis C haemodialysis patients - Recommendions based series.

Interferon treatment for chronic hepatitis C infection in hemophiliacs: Influence of virus load, genotype, and liver pathology on response

Interferon cure chronic hepatitis C - Assessment 3 regimen patients received 500MU interferon cure influence predictive factors interferon cure multivariate examination logistic regression model.

Interferon cure chronic hepatitis patients comparison daily day administration based histology activity index intrahepatic hbc hbs antigens.

Interferon cure dilated cardiomyopathy striated myopathy hepatitis C virus infection based serial measurements serum concentrations cardiac troponin T.

Interferon cure hairy cell leukemia - An update cohort 69 patients treated 1983-1986.

Interferon cure hepatitis B-associated membranous glomerulonephritis Chinese children.

Interferon treatment for hepatitis C virus infection in patients on haemodialysis

Interferon cure hypereosinophilic syndromes systemic mastocytosis.

Interferon cure multiple sclerosis patients Hong Kong.

Interferon treatment for multiple sclerosis: Autoimmune complications may be lethal.

Interferon cure patients chronic hepatitis C infested high viral load genotype 2 virus.

Interferon cure thrombocytopenia chronic HCV infection.

Interferon cure acute hepatitis infection extended.

Interferon cure acute progressive fulminant hepatitis.

Interferon cure children chronic hepatitis B.

Interferon cure children chronic hepatitis C - Long-lasting remission responders, risk disease progression non-responders.

Interferon cure cryoglobulinemic membranoproliferative glomerulonephritis hepatitis C virus infection.

Interferon cure patients chronic hepatitis B. meta-analysis published literature.

Interferon cure patients chronic hepatitis C normal alanine-aminotransferase activity.

Interferon cure patients metastatic renal adenocarcinoma preliminary report effects kinds interferons.

Interferon cure inhibits early events vaccinia virus gene expression infested mice.

Interferon cure inhibits glycosylation viral protein.

Interferon cure inhibits onset herpes simplex virus early transcription.

Interferon cure inhibits onset herpes simplex virus immediate-early transcription.

Interferon cure inhibits replication simian immunoinsufficiency virus early stage - Proof block attachment reverse transcription.

Interferon cure inhibits replication simian immunoinsufficiency virus early stage - proof block attachment reverse transcription.

Interferon cure inhibits virus replication HIV-1 SIV-infected CD4+ T-cell lines distinct mechanisms - Proof decreased stability aberrant processing HIV-1 proteins.

Interferon cure inhibits virus replication HIV-1 SIV-infected CD4+ T-cell lines distinct mechanisms - proof decreased stability aberrant processing HIV-1 proteins.

Interferon cure worsening psychiatric symptoms patients hepatitis C.

Interferon cure markedly inhibits progress tumor metastases liver spleen increases survival time mice intravenous inoculation friend erythroleukemia cells.

Interferon cure trigger primary headaches multiple sclerosis patients.

Interferon cure HCV positive cirrhotic patients.

Interferon cure Mooren's ulcers hepatitis C.

Interferon cure transplantable rat colon adeno carcinoma importance tumor site.

Interferon cure adenoviral conjunctivitis.

Interferon treatment of childhood conjunctival lymphoma

Interferon cure children chronic hepatitis C.

Interferon cure chronic active hepatitis C therapy acute lymphoblastic leukemia.

Interferon cure chronic active hepatitis C patients end-stage chronic renal failure.

Interferon cure chronic hepatitis C.

Interferon cure chronic hepatitis surface antigen hbsag carriers description activation profiles natural killer cells attained diverse schedules administration subsets carriers.

Interferon cure circovirus infection grey parrots (Psittacus erithacus).

Interferon cure circovirus infection grey parrots (Psittacus e. erithacus).

Interferon cure experimental ross river virus polymyositis.

Interferon cure hep 2 cells alters adhesive ability pseudomonas aeruginosa.

Interferon cure human genital papillomavirus infection importance viral type.

Interferon cure human neoplasia.

Interferon cure human stomach breast carcinoma xenografts nude mice.

Interferon treatment of mice enhanced expression of histo compatibility antigens on lymphoid cells

Interferon cure mouse ehrlich ascites tumor cells effects exogenous messenger rna translation transfer rna inactivation cell extract.

Interferon cure murine meth sarcoma cells effects malignant phenotype expression tumor special 2 antigens.

Interferon cure neuroendocrine tumour xenografts monitored MRI.

Interferon cure zealand black mice accelerated progression auto immune disease.

Interferon cure porphyria cutanea tarda chronic hepatitis type C.

Interferon cure refractory idiopathic thrombocytopenic purpura (ITP).

Interferon cure patients quadruple infection hepatitis C virus (HCV), human immunoinsufficiency virus (HIV), hepatitis G virus (HGV), TT virus (TTV).

Interferon cure uterine cervical carcinoma - 20 years follow-up.

Interferon treatment of uterine cervical pre cancerosis

Interferon treatment on glomerulonephritis associated with hepatitis C virus

Interferon cure lung metastases renal cell carcinoma reviews complete answer 2 cases.

Interferon cure reduced adherence, invasiveness intracellular multiplication Shigella flexneri coxsackie B1 virus-infected cells.

Interferon cure reduces endocytosis virus facultatively intracellular bacteria cell lines.

Interferon trials cell lung cancer institution. comparison results attained initiation systematic cure trials IFN-alpha combination modalities.

Interferon type I and type II responses in an Atlantic salmon (Salmo salar) SHK-1 cell line by the salmon TRAITS/SGP microarray

Interferon type I downregulates human parainfluenza virus type 3-induced major histocompatibility complex class II expression.

Interferon type I gene expression chronic hepatitis C.

Interferon type I receptor-lacking mice altered disease symptoms answer influenza virus.

Interferon type I response in porcine reproductive and respiratory syndrome virus-infected MARC-145 cells

Interferon type I responses primary secondary infections.

Interferon type alpha and gamma production by fresh and cryo preserved human mononuclear cells brief report

Interferon type-I responses primary secondary viral infections.

Interferon update

Interferon interferon prednisone remission maintenance therapy multiple myeloma.west Oncology Group Investigation.

Interferon ribavirin interferon chronic hepatitis C previously tolerant interferon. randomized experiment.

Interferon steroids patients hepatitis C virus-associated cryoglobulinaemic glomerulonephritis.

Interferon vs. adenine arabinoside 5-monophosphate patients anti-HBe-positive chronic hepatitis.

Interferon characteristics produced human mononuclear leukocytes.

Interferon yield and MHC antigen expression of human medulloblastoma cells and its suppression during dibutyryl cyclic AMP-induced differentiation: Do medulloblastoma cells derive from bipotent neuronal and glial progenitors?

Interferon's horizons broaden.

Interferon, Mx, viral countermeasures.

Interferon, PKR, virology, genomics - What millennium?

Interferon current therapeutic substance treating papillomatosis udder bovine malignant catarrh.

Interferon growing cytokine family - 50 years interferon science.

Interferon, alpha 17 (IFNA17) Ile184Arg polymorphism cervical cancer risk.

Interferon, antibody responses protection stimulated intranasal infectious bovine rhinotracheitis vaccine.

Interferon, cortisone, antivirals cure chronic viral hepatitis. review 30 years therapy.

Interferon, fluorescent antibody, neutralizing antibody responses sera calves inoculated bovine respiratory syncytial virus.

Interferon, ribavirin, 6-azauridine glycyrrhizin - Antiviral compounds active pathogenic flaviviruses.

Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses

Interferon, ribonucleic acid foot mouth disease virus.

Interferon, oxytocin receptor maternal recognition pregnancy ruminants non-ruminants. comparative advance.

Interferon- Down-regulates Adenosine 2b Receptor-mediated Signaling and Short Circuit Current in the Intestinal Epithelia by Inhibiting the Expression of Adenylate Cyclase

Interferon- activation mitogen-activated protein kinase, KFR1, bloodstream form Trypanosoma brucei.

Interferon- alpha - evolving therapy AIDS-associated Kaposi's sarcoma.

Interferon- alpha : gamma differentially reduce fast immature T-cell death contact HIV-1 carrier cell clones vitro.

Interferon- alpha and - gamma expression in the rat testis

Interferon- alpha synthetic peptide malaria sporozoite vaccine non-immune adults - antibody answer 40 weeks.

Interferon- alpha enhances artemisinin-induced differentiation of HL-60 leukemia cells via a PKC alpha /ERK pathway.

Interferon- alpha genes from Bos and Bubalus bubalus

Interferon- alpha reproductive hormone.

Interferon- alpha mimics effects ovine trophoblast protein 1 prostaglandin protein secretion ovine endometrial cells vitro.

Interferon- alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes

Interferon- and sarcolectin-dependent cellular regulatory interactions

Interferon- streptolysin O-induced activation protein kinases inhibition cytochrome P450-dependent monooxygenases rats.

Interferon- beta 1a SARS coronavirus replication.

Interferon- gamma -activated immature macrophages exhibit high Trypanosoma cruzi infection rate production nitric oxide tumor necrosis factor- alpha.

Interferon- gamma -activated primary enterocytes inhibit Toxoplasma gondii replication. function intracellular iron.

Interferon- gamma -independent CD8+ T cell-mediated protective anti-malaria immunity elicited recombinant adenovirus.

Interferon- gamma -induced inhibition of neuronal vesicular stomatitis virus infection is STAT1 dependent

Interferon- gamma -induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice

Interferon- gamma -induced tryptophan degradation: relevance in immunology and psychiatry

Interferon- gamma -mediated inhibition progress Eimeria tenella cultured cells.

Interferon- gamma - major mediator resistance Toxoplasma gondii.

Interferon- gamma activates rat alveolar macrophages anticryptococcal activity.

Interferon- gamma activation of a mitogen-activated protein kinase, KFR1, in the bloodstream form of Trypanosoma brucei

Interferon- gamma factor derived trypanosomes behavioural rat.

Interferon- gamma colony-stimulating factors adjuvant therapy refractory fungal infections children.

Interferon- gamma and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis.

Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes

Interferon- gamma interleukin 4 gene expression cows infested Mycobacterium paratuberculosis.

Interferon- gamma and interleukin-12 mediate protection to acute Neospora caninum infection in BALB/c mice

Interferon- gamma and interleukin-4 mRNA expression by peripheral blood mononuclear cells from pregnant and non-pregnant cattle seropositive for bovine viral diarrhea virus

Interferon- gamma interleukin-4 production human T cells recognizing Leishmania donovani antigens separated SDS-PAGE.

Interferon- gamma interleukin-4 production ovalbumin-stimulated lymphocytes egg-sensitive children.

Interferon- gamma interleukin-4 responses relationship serum IgE levels persons infested human T lymphotropic virus type I Strongyloides stercoralis.

Interferon- gamma and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 infections

Interferon- gamma and nitric oxide production are not required for the immune-mediated clearance of Brugia malayi microfilariae in mice

Interferon- gamma and tumor necrosis factor- alpha levels in sera and whey of cattle with naturally occurring coliform mastitis

Interferon- gamma tumor necrosis factor- alpha protect mice invasive aspergillosis.

Interferon- gamma antagonizes transforming growth factor- beta 2-mediated immunosuppression murine Toxoplasma encephalitis.

Interferon- gamma key cytokine immunological process.

Interferon- gamma conventional therapy recurrent visceral leishmaniasis patient AIDS.

Interferon- gamma contributes to the normalcy of murine pregnancy

Interferon- gamma deficiency reveals that 129Sv mice are inherently more susceptible to Anaplasma phagocytophilum than C57BL/6 mice

Interferon- gamma enhances influence antimalarial chemotherapy murine Plasmodium vinckei malaria.

Interferon- gamma expression suppression bovine leukemia virus early phase infection sheep.

Interferon- gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion

Interferon- gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells

Interferon- gamma stimulated lethality late phase Plasmodium vinckei malaria effective parasite clearance chloroquine.

Interferon- gamma induces secretion of trypanosome lymphocyte triggering factor via tyrosine protein kinases

Interferon- gamma induction of major histocompatibility complex antigens on cultured bovine luteal cells

Interferon- gamma inhibits growth Coxiella burnetii mouse fibroblasts.

Interferon- gamma inhibits induced adrenocorticotropin, prolactin, growth hormone secretion normal rat anterior pituitary cell cultures.

Interferon- gamma inhibits efficacy interleukin 1 generate Th2-cell biased immune answer stimulated Leishmania major.

Interferon- gamma inhibits the steroidogenic acute regulatory protein messenger ribonucleic acid expression and protein levels in primary cultures of rat Leydig cells

Interferon- gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice

Interferon- gamma essential progress cerebral malaria.

Interferon- gamma is expressed in both gut and spleen during Eimeria tenella infection

Interferon- gamma is required for innate immunity to Cryptosporidium parvum in mice

Interferon- gamma mediates long-term persistent Chlamydia psittaci infection vitro.

Interferon- gamma production exposure trichophytin peripheral blood mononuclear cells patients acute dermatophyte infection.

Interferon- gamma production peripheral blood mononuclear cells residents region endemic Schistosoma mansoni.

Interferon- gamma production in peripheral lymphocytes of patients with tinea pedis: comparison of patients with and without tinea unguium

Interferon- gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV

Interferon- gamma production mitogen induced peripheral lymphocytes perinatal cows.

Interferon- gamma promotes abortion due Brucella infection pregnant mice.

Interferon- gamma protects endothelial cells damage Candida albicans.

Interferon- gamma receptor-insufficiency renders mice highly vulnerable toxoplasmosis decreased macrophage activation.

Interferon- gamma reduces capacity human alveolar macrophages inhibit growth Cryptococcus neoformans vitro.

Interferon- gamma responses resistance reinfection Plasmodium falciparum young African children.

Interferon- gamma signal transduction parasite infection - modulation MAP kinases infection human monocyte cells (THP1) Toxoplasma gondii.

Interferon- gamma suppresses growth Toxoplasma gondii human fibroblasts starvation tryptophan.

Interferon- gamma test for feline tuberculosis

Interferon- gamma therapy in two patients with progressive chronic pulmonary aspergillosis

Interferon- gamma treatment induces granulomatous tissue reaction in a case of localized cutaneous leishmaniasis

Interferon- induces internalization of epithelial tight junction proteins via a macropinocytosis-like process

Interferon- induces secretion trypanosome lymphocyte triggering factor tyrosine protein kinases.

Interferon- interleukin-10 production stimulated similar Trypanosoma cruzi antigens.

Interferon- selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores

Interferon- tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells

Interferon- tau blocks the stimulatory effect of tumor necrosis factor- alpha on prostaglandin F2 alpha synthesis by bovine endometrial stromal cells

Interferon- tau in bovine blastocysts following parthenogenetic activation of oocytes: pattern of secretion and polymorphism in expressed mRNA sequences

Interferon- tau modulates phorbol ester-induced production of prostaglandin and expression of cyclooxygenase-2 and phospholipase-A2 from bovine endometrial cells

Interferon- tau stimulates secretion of macrophage migration inhibitory factor from bovine endometrial epithelial cells

Interferon- tau upregulates prolactin receptor mRNA in the ovine endometrium during the periimplantation period

Interferon-(Sb(B Mediates Opposing Effects on Interferon-(Sd(B-dependent Interleukin-12 p70 Secretion by Human Monocyte-Derived Dendritic Cells

Interferon-(Sb(B therapy reduces CD4 superscript +(B and CD8 superscript +(B T-cell reactivity in multiple sclerosis

Interferon-(Sd(B expression associated with suppression of bovine leukemia virus at the early phase of infection in sheep

Interferon-(Sd(B inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levels

Interferon-(Sd(B regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro

Interferon-(Sd(B-inducible Protein (IP)-10 mRNA Stabilized by RNA-binding Proteins in Monocytes Treated with S100b

Interferon--induced Expression of Phospholipid Scramblase 1 through STAT1 Requires the Sequential Activation of Protein Kinase C and JNK

Interferon--its induction, properties, detection, effect general importance.

Interferon--research, medical function, regulatory consideration.

Interferon-A 2a administration chronic anergic brucellosis.

Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical

Interferon-Induced Alterations in the Pattern of Parainfluenza Virus 5 Transcription and Protein Synthesis and the Induction of Virus Inclusion Bodies

Interferon-Induced Expression MxA Respiratory Tract Rhesus Macaques Is Suppressed Influenza Virus Replication.

Interferon-Inducible Protein 10, but Not Monokine Induced by Gamma Interferon, Promotes Protective Type 1 Immunity in Murine Klebsiella pneumoniae Pneumonia

Interferon-Inducible Protein 9 (CXCL11)-Induced Cell Motility in Keratinocytes Requires Calcium Flux-Dependent Activation of m-Calpain

Interferon-Inducible Ubiquitin E2, Ubc8, Is a Conjugating Enzyme for Protein ISGylation

Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome

Interferon-Tau suppresses prostaglandin F2 alpha secretion independently of the mitogen-activated protein kinase and nuclear factor kappa B pathways

Interferon-a activates signal transducers activators transcription 5 6 Daudi cells.

Interferon-a acts preoptic hypothalamus reduce natural killer cytotoxicity rats.

Interferon-a alters IgE receptor-dependent cytokine production human circulating monocytoid dendritic cells.

Interferon-a and -b differentially regulate osteoclastogenesis: Role of differential induction of chemokine CXCL11 expression

Interferon-a interferon-c differentially affect pancreatic b-cell phenotype role.

Interferon-a augments FcERI-dependent production autoregulatory IL-10 human blood monocytoid dendritic cells.

Interferon-a down-regulates insulin receptors in lymphoblastoid (Daudi) cells. Relationship to inhibition of cell proliferation

Interferon-a downregulates expression oxytocin receptor cultured human myometrial cells.

Interferon-a engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3'-kinase

Interferon-a induces Nmi-IFP35 heterodimeric complex formation that is affected by the phosphorylation of IFP35

Interferon-a induces the expression of the L-selectin homing receptor in human B lymphoid cells

Interferon-a induces transient upregulation c-FLIP NF-kb activation.

Interferon-a inhibits murine cytomegalovirus immediate-early gene expression down-regulating NF-kB activity.

Interferon-a selectively activates the b isoform of protein kinase C through phosphatidylcholine hydrolysis

Interferon-a synergistically enhances induction of interleukin-6 by double stranded RNA in HeLa cells

Interferon-a treatment of Daudi cells down-regulates the octamer binding transcription/DNA replication factors Oct-1 and Oct-2

Interferon-a-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase

Interferon-a-induced Expression of Phospholipid Scramblase 1 through STAT1 Requires the Sequential Activation of Protein Kinase C and JNK

Interferon-a-induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three

Interferon-a/b inhibition of interleukin 12 and interferon-c production in vitro and endogenously during viral infection

Interferon-a2b reduces neo-microvascular density normal urothelium adjacent tumor transurethral resection superficial bladder carcinoma.

Interferon-activated neutrophils store TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool readily mobilizable exposure proinflammatory mediators.

Interferon-alfa cure essential thrombocythemia pregnancy.

Interferon-alfa cure facial infantile haemangiomas - With emphasis sight-threatening cultivars - medical series.

Interferon-alfa-2a advanced renal cell carcinoma - Treatment results survival 159 patients long-term follow-up.

Interferon-alpha (IFN-alpha) enhances cytotoxicity healthy volunteers chronic hepatitis C infection perforin pathway.

Interferon-alpha (IFN-alpha) induces cytolytic mechanism ovarian carcinoma cells protein kinase C-dependent pathway.

Interferon-alpha (IFN-alpha) inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF) expression post-transcriptional degree murine bone marrow stromal cells.

Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation mixed lymphocyte tumour cultures (MLTC).

Interferon-alpha (IFN-alpha) administration interfering successfully prevents growth 786-O renal cell carcinoma (RCC).

Interferon-alpha (IFN-alpha)-conditioned DC preferentially induce type-1 limit T-reg-type vitro T-cell responses RCC patients.

Interferon-alpha (INF-alpha) etretinate cure mycosis fungoides.

Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression

Interferon-alpha therapeutic option refractory juvenile Behcets disease CNS involvement.

Interferon-alpha 2a and Vogt-Koyanagi-Harada disease: a double-edged sword?

Interferon-alpha 2a sufficient promoting dendritic cell immunogenicity.

Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice

Interferon-alpha 2a/ribavirin interferon-alpha 2a retreatment hepatitis C patients relapse standard interferon.

Interferon-alpha 2b (IFN-alpha) early-phase chronic lymphocytic leukaemia high risk disease progression - Results randomized multicentre study.

Interferon-alpha 2b Enhances Barrier Function Bovine Retinal Microvascular Endothelium Vitro.

Interferon-alpha 2b vesnarinone effect levels tumor necrosis factor-alpha, apoptosis, interleukin 6 eskol hairy cell leukemic cell line - potential cytokine oncogene relation regulating apoptosis suggested.

Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: A prospective and randomised trial

Interferon-alpha 2b impair myelinization rat optic nerve.

Interferon-alpha 2b ribavirin patients chronic hepatitis C liver transplantation. randomized study.

Interferon-alpha 2b protease inhibitor-based antiretroviral therapy patients AIDS-associated Kaposi sarcoma: An AIDS malignancy consortium phase I experiment.

Interferon-alpha 2b-induced thrombocytopenia attributable inhibition cytoplasmic maturation platelet production, not, proliferation endomitosis human megakaryocytes.

Interferon-alpha 2b-induced thrombocytopenia attributable inhibition platelet production proliferation endomitosis human megakaryocytes.

Interferon-alpha Elicits Downregulation Human Papillomavirus 18 mRNA HeLa Cells Selective Repression Endogenous Viral Transcription.

Interferon-alpha Treatment Patients Chronic Hepatitis C. Meta-Analytic Evaluation.

Interferon-alpha prevents apoptosis endothelial cells short-term exposure induces replicative senescence continuous stimulation.

Interferon-alpha activates binding nuclear factors sequence element c-fos proto-oncogene 5-flanking area.

Interferon-alpha activates cytotoxic function but inhibits interleukin-2 mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells

Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells

Interferon-alpha activates multiple STAT signals down-regulates c-Met primary human hepatocytes.

Interferon-alpha activates signal transducers activators transcription 5 6 Daudi cells.

Interferon-alpha activity in a case of severe autoimmune lymphoproliferative disease

Interferon-alpha acts preoptic hypothalamus reduce natural killer cytotoxicity rats.

Interferon-alpha acutely impairs sleep healthy humans.

Interferon-alpha affects immune answer post-transplant lymphoproliferative disorder.

Interferon-alpha affects tumour necrosis factor-alpha content mast cells human nasal mucosa - pilot study allergic patients.

Interferon-alpha autologous stem cell transplantation pediatric patients advanced Hodgkin's lymphoma.

Interferon-alpha alters spectrin organization in normal and leukemic human B lymphocytes

Interferon-alpha and -beta differentially regulate osteoclastogenesis: Role of differential induction of chemokine CXCL11 expression

Interferon-alpha -beta Chronic Hepatitis C - Efficacy Tolerability. Comparative Pilot Investigation.

Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14+ precursors

Interferon-alpha -beta restrict polyomavirus JC replication primary human fetal glial cells - Implications progressive multifocal leukoencephalopathy therapy.

Interferon-alpha -gamma differentially reduce fast immature T-cell death contact HIV-1 carrier cell clones vitro.

Interferon-alpha and -gamma expression in the rat testis

Interferon-alpha -gamma inhibit growth neoplastic potential V-src-transformed human epithelial cells reducing Src tyrosine kinase activity.

Interferon-alpha -y combination chemotherapeutic drugs - In vitro sensitivity investigations human mesothelioma cell lines.

Interferon-alpha 13-cis-retinoic acid maintenance therapy high-dose combination chemotherapy growth factor support cell lung cancer. feasibility study.

Interferon-alpha 5-fluorouracil combination therapy palliative hepatic resection patients advanced hepatocellular carcinoma, portal venous tumor thrombus major trunk, multiple nodules.

Interferon-alpha 5-fluorouracil therapy patients metastatic renal cell cancer - An open multicenter experiment.

Interferon-alpha and IDDM: Comment

Interferon-alpha all-trans-retinoic acid reversibly inhibit vitro proliferation cell lines derived cervical cancers.

Interferon-alpha cancer - Mechanisms effect perspectives medical.

Interferon-alpha chemohormonal therapy patients advanced melanoma - Final results phase I-II Investigation Cancer Biotherapy Research Group Mid-Atlantic Oncology Program.

Interferon-alpha dexamethasone influence AF10 myeloma cell line sialyltransferase activity.

Interferon-alpha donor buffy coat transfusions cure relapsed chronic myeloid leukemia allogeneic bone marrow transplantation.

Interferon-alpha gemcitabine (2,2-difluorodeoxycytidine) adult pediatric renal tumors.

Interferon-alpha glutathione combination therapy patients chronic hepatitis C.

Interferon-alpha granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes potent antigen-presenting cells.

Interferon-alpha and haptoglobin in pigs selectively bred for high and low immune response and infected with Mycoplasma hyorhinis

Interferon-alpha interferon-gamma augment apoptosis oral carcinoma cells treated shiga toxin 2 (Stx2).

Interferon-alpha interferon-gamma combined chemotherapy - In vitro sensitivity investigations non-small cell lung cancer cell lines.

Interferon-alpha interferon-gamma differentially affect pancreatic beta-cell phenotype role.

Interferon-alpha interferon-gamma down-regulate production interleukin-8 ENA-78 human monocytes.

Interferon-alpha interferon-gamma advanced renal cell carcinoma - Treatment results, survival, prognostic factors 81 patients.

Interferon-alpha interferon-gamma stimulated modulation proteins human corneal fibroblasts.

Interferon-alpha interferon-gamma sensitize human tenon fibroblasts mitomycin-C.

Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth

Interferon-alpha and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets

Interferon-alpha and interleukin-12 gene therapy of cancer: Interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing

Interferon-alpha interleukin-2 cure metastatic melanoma - Comparison phase II trials.

Interferon-alpha lamivudine combination therapy children chronic hepatitis B infection interferon-alpha nonresponders.

Interferon-alpha and p53 alleles involved in nasopharyngeal carcinoma

Interferon-alpha ribavirin cure recurrent hepatitis C liver transplantation.

Interferon-alpha ribavirin resistance Huh7 cells transfected HCV subgenomic replicon.

Interferon-alpha ribavirin cure hepatitis C children malignancy remission.

Interferon-alpha survival metastatic renal carcinoma - Early results randomised controlled experiment.

Interferon-alpha survival renal cell cancer.

Interferon-alpha pathogenesis myeloproliferative disorders.

Interferon-alpha transforming growth factor-beta-1 regulate corticotropin-releasing factor release amygdala - Comparison hypothalamic answer.

Interferon-alpha viral triggers promote functional maturation human monocyte-derived dendritic cells.

Interferon-alpha zidovudine combination therapy chronic hepatitis B - Results randomized, placebo-controlled experiment.

Interferon-alpha antibodies patients renal cell carcinoma treated recombinant interferon-alpha-2A adjuvant multicenter experiment.

Interferon-alpha as a mediator of polyinosinic : polycytidylic acid-induced type 1 diabetes

Interferon-alpha cure modality colchicine-resistant familial Mediterranean fever.

Interferon-alpha adjuvant cure chronic schizophrenia.

Interferon-alpha effective cure noninfectious posterior uveitis Panuveitis.

Interferon-alpha immunotherapeutic protein.

Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: Long term results of the Karolinska Hospital series

Interferon-alpha arthritis.

Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure

Interferon-alpha beta mediates partial control early pulmonary Mycobacterium bovis bacillus Calmette-Guerin infection.

Interferon-alpha combined with radiotherapy in the treatment of unresectable melanoma

Interferon-alpha controls IL-17 expression in vitro and in vivo

Interferon-alpha delays S-phase progression human hepatocellular carcinoma cells inhibition special cyclin-dependent kinases.

Interferon-alpha differentially rescues CD4 CD8 T cells apoptosis HIV infection.

Interferon-alpha inhibits DNA polymerase activity extracted chromatin nucleoprotein complexes - Correlation IFN-alpha cure outcome patients chronic myelogenous leukemia.

Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1

Interferon-alpha disables dendritic cell precursors - Dendritic cells derived interferon-alpha-treated monocytes defective maturation T-cell stimulation.

Interferon-a